Veradermics MANE
NYSE MANE
$127.10 +4.82 (+3.94%)
As of: Oct 20, 2026 · 3:59 PM EDT

Veradermics (MANE) EBIT (2025 - 2026)

Updated

Veradermics (MANE) recorded EBIT of -$29.55 million in Q2 2026, compared with -$16.07 million a year earlier.

Analysis

Veradermics (MANE) EBIT (2025 - 2026) Analysis & Trends

On a TTM basis, Veradermics' EBIT came in at -$88.4 million as of Jun 30, 2026; for FY2025, it was -$72.35 million.

  • Across earlier years, EBIT came in at -$26.78 million in FY2024.
  • Quarterly EBIT has ranged from -$29.86 million in Q1 2026 to -$12.92 million in Q1 2025 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 7.14 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 6.43 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 3.16 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -10.39 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 4.27 Bn
10 Veradermics 5.17 Bn 3.77 Bn - -29.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -29.55 Mn
Mar 31, 2026 -29.86 Mn
Jun 30, 2025 -16.07 Mn
Mar 31, 2025 -12.92 Mn
API Access

Veradermics EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=MANE&period=max&api_key=YOUR_API_KEY